FDA Warning Letter: Intas Pharmaceuticals Limited
CGMP/Finished Pharmaceuticals/Adulterated. Issued by FDA Center for Drug Evaluation and Research | CDER on 2023-11-21.
FDA Center for Drug Evaluation and Research | CDER